Kimberley M. Mellor , Upasna Varma , Parisa Koutsifeli , Lorna J. Daniels , Victoria L. Benson , Marco Annandale , Xun Li , Yohanes Nursalim , Johannes V. Janssens , Kate L. Weeks , Kim L. Powell , Terence J. O'Brien , Rajesh Katare , Rebecca H. Ritchie , James R. Bell , Roberta A. Gottlieb , Lea M.D. Delbridge
{"title":"心肌糖吞噬通量失调和糖原累积是糖尿病心肌病的特征","authors":"Kimberley M. Mellor , Upasna Varma , Parisa Koutsifeli , Lorna J. Daniels , Victoria L. Benson , Marco Annandale , Xun Li , Yohanes Nursalim , Johannes V. Janssens , Kate L. Weeks , Kim L. Powell , Terence J. O'Brien , Rajesh Katare , Rebecca H. Ritchie , James R. Bell , Roberta A. Gottlieb , Lea M.D. Delbridge","doi":"10.1016/j.yjmcc.2024.02.009","DOIUrl":null,"url":null,"abstract":"<div><p>Diabetic heart disease morbidity and mortality is escalating. No specific therapeutics exist and mechanistic understanding of diabetic cardiomyopathy etiology is lacking. While lipid accumulation is a recognized cardiomyocyte phenotype of diabetes, less is known about glycolytic fuel handling and storage. Based on in vitro studies, we postulated the operation of an autophagy pathway in the myocardium specific for glycogen homeostasis – glycophagy. Here we visualize occurrence of cardiac glycophagy and show that the diabetic myocardium is characterized by marked glycogen elevation and altered cardiomyocyte glycogen localization. We establish that cardiac glycophagy flux is disturbed in diabetes. Glycophagy may represent a potential therapeutic target for alleviating the myocardial impacts of metabolic disruption in diabetic heart disease.</p></div>","PeriodicalId":16402,"journal":{"name":"Journal of molecular and cellular cardiology","volume":null,"pages":null},"PeriodicalIF":4.9000,"publicationDate":"2024-03-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0022282824000348/pdfft?md5=51d153eaf3e8c191b20f9b2d30c11d2b&pid=1-s2.0-S0022282824000348-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Myocardial glycophagy flux dysregulation and glycogen accumulation characterize diabetic cardiomyopathy\",\"authors\":\"Kimberley M. Mellor , Upasna Varma , Parisa Koutsifeli , Lorna J. Daniels , Victoria L. Benson , Marco Annandale , Xun Li , Yohanes Nursalim , Johannes V. Janssens , Kate L. Weeks , Kim L. Powell , Terence J. O'Brien , Rajesh Katare , Rebecca H. Ritchie , James R. Bell , Roberta A. Gottlieb , Lea M.D. Delbridge\",\"doi\":\"10.1016/j.yjmcc.2024.02.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Diabetic heart disease morbidity and mortality is escalating. No specific therapeutics exist and mechanistic understanding of diabetic cardiomyopathy etiology is lacking. While lipid accumulation is a recognized cardiomyocyte phenotype of diabetes, less is known about glycolytic fuel handling and storage. Based on in vitro studies, we postulated the operation of an autophagy pathway in the myocardium specific for glycogen homeostasis – glycophagy. Here we visualize occurrence of cardiac glycophagy and show that the diabetic myocardium is characterized by marked glycogen elevation and altered cardiomyocyte glycogen localization. We establish that cardiac glycophagy flux is disturbed in diabetes. Glycophagy may represent a potential therapeutic target for alleviating the myocardial impacts of metabolic disruption in diabetic heart disease.</p></div>\",\"PeriodicalId\":16402,\"journal\":{\"name\":\"Journal of molecular and cellular cardiology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.9000,\"publicationDate\":\"2024-03-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0022282824000348/pdfft?md5=51d153eaf3e8c191b20f9b2d30c11d2b&pid=1-s2.0-S0022282824000348-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of molecular and cellular cardiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0022282824000348\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of molecular and cellular cardiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022282824000348","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Myocardial glycophagy flux dysregulation and glycogen accumulation characterize diabetic cardiomyopathy
Diabetic heart disease morbidity and mortality is escalating. No specific therapeutics exist and mechanistic understanding of diabetic cardiomyopathy etiology is lacking. While lipid accumulation is a recognized cardiomyocyte phenotype of diabetes, less is known about glycolytic fuel handling and storage. Based on in vitro studies, we postulated the operation of an autophagy pathway in the myocardium specific for glycogen homeostasis – glycophagy. Here we visualize occurrence of cardiac glycophagy and show that the diabetic myocardium is characterized by marked glycogen elevation and altered cardiomyocyte glycogen localization. We establish that cardiac glycophagy flux is disturbed in diabetes. Glycophagy may represent a potential therapeutic target for alleviating the myocardial impacts of metabolic disruption in diabetic heart disease.
期刊介绍:
The Journal of Molecular and Cellular Cardiology publishes work advancing knowledge of the mechanisms responsible for both normal and diseased cardiovascular function. To this end papers are published in all relevant areas. These include (but are not limited to): structural biology; genetics; proteomics; morphology; stem cells; molecular biology; metabolism; biophysics; bioengineering; computational modeling and systems analysis; electrophysiology; pharmacology and physiology. Papers are encouraged with both basic and translational approaches. The journal is directed not only to basic scientists but also to clinical cardiologists who wish to follow the rapidly advancing frontiers of basic knowledge of the heart and circulation.